Literature Citations
1. Synthesis, Structure-Activity Relationship, and Mechanistic Studies of Aminoquinazolinones Displaying Antimycobacterial Activity. Akester, J.N., P. Njaria, A. Nchinda, C. Le Manach, A. Myrick, V. Singh, N. Lawrence, M. Njoroge, D. Taylor, A. Moosa, A.J. Smith, E.J. Brooks, A.J. Lenaerts, G.T. Robertson, T.R. Ioerger, R. Mueller, and K. Chibale. ACS Infectious Diseases, 2020. 6(7): p. 1951-1964. PMID[32470286]. PMCID[PMC7359024].
[PubMed]. TB_07_2020.
2. 2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry. Azzali, E., M. Girardini, G. Annunziato, M. Pavone, F. Vacondio, G. Mori, M.R. Pasca, G. Costantino, and M. Pieroni. ACS Medicinal Chemistry Letters, 2020. 11(7): p. 1435-1441. PMID[32676151]. PMCID[PMC7357219].
[PubMed]. TB_07_2020.
3. Antimicrobial Peptides against Drug Resistant Mycobacterium abscessus. da Silva, J.L., S. Gupta, K.N. Olivier, and A.M. Zelazny. Research in Microbiology, 2020. 171(5-6): p. 211-214. PMID[32198075]. PMCID[PMC7369229].
[PubMed]. TB_07_2020.
4. Discovery and Evaluation of New Compounds Targeting Ribosomal Protein S1 in Antibiotic-resistant Mycobacterium tuberculosis. Dai, Y., Y. Xu, C. Guo, X. Xue, D. Lin, and K. Lin. European Journal of Medicinal Chemistry, 2020. 196: e112317. PMID[32311606].
[PubMed]. TB_07_2020.
5. Design and Synthesis of Thiourea-based Derivatives as Mycobacterium tuberculosis Growth and Enoyl Acyl Carrier Protein Reductase (InhA) Inhibitors. Doğan Ş, D., M.G. Gündüz, H. Doğan, V.S. Krishna, C. Lherbet, and D. Sriram. European Journal of Medicinal Chemistry, 2020. 199: e112402. PMID[32417538].
[PubMed]. TB_07_2020.
6. Discovery of the First Mycobacterium tuberculosis MabA (FabG1) Inhibitors through a Fragment-based Screening. Faïon, L., K. Djaout, R. Frita, C. Pintiala, F.X. Cantrelle, M. Moune, A. Vandeputte, K. Bourbiaux, C. Piveteau, A. Herledan, A. Biela, F. Leroux, L. Kremer, M. Blaise, A. Tanina, R. Wintjens, X. Hanoulle, B. Déprez, N. Willand, A.R. Baulard, and M. Flipo. European Journal of Medicinal Chemistry, 2020. 200: e112440. PMID[32505086].
[PubMed]. TB_07_2020.
7. 2-Aminoaryl-3,5-diaryl pyrazines: Synthesis, Biological Evaluation against Mycobacterium tuberculosis and Docking Studies. Gangarapu, N.R., A. Ranganatham, E.K. Reddy, S. Yellappa, and K.B. Chandrasekhar. Archiv der Pharmazie, 2020. 353(7): e1900368. PMID[32399980].
[PubMed]. TB_07_2020.
8. Design, Synthesis and Biological Evaluation of Novel 6-(Trifluoromethyl)-N-(4-oxothiazolidin-3-yl)quinazoline-2-carboxamide Derivatives as a Potential DprE1 Inhibitors. Gawad, J. and C. Bonde. Journal of Molecular Structure, 2020. 1217: e128394. ISI[000544054000003].
[WOS]. TB_07_2020.
9. Synthesis and Characterization of N '-(11H-Indeno[1,2-b]quinoxalin-11-ylidene)benzohydrazonamides as Potential Antimicrobial Agents. Gomaa, M.A.M., M.H. El-Katatny, and H.A. Ali. Synthetic Communications, 2020. 50: p. 1-11. ISI[000546744700001].
[WOS]. TB_07_2020.
10. New Leads for the Treatment of Multidrug Resistant Mycobacterium tuberculosis. Herzon, S.B. ACS Central Science, 2020. 6(6): p. 833-835. PMID[32607429]. PMCID[PMC7318060].
[PubMed]. TB_07_2020.
11. 1-(1-Arylethylpiperidin-4-yl)thymine Analogs as Antimycobacterial TMPK Inhibitors. Jian, Y., F. Hulpia, D.P.R. M, H.E. Forbes, G. Caljon, H. Munier-Lehmann, I.M.B. H, and S. Van Calenbergh. Molecules, 2020. 25(12): e2805. PMID[32560578]. PMCID[PMC7356956].
[PubMed]. TB_07_2020.
12. Synthesis and Structure Activity Relationships of Cyanopyridone Based Anti-tuberculosis Agents. Jian, Y., F. Hulpia, M.D.P. Risseeuw, H.E. Forbes, H. Munier-Lehmann, G. Caljon, H.I.M. Boshoff, and S. Van Calenbergh. European Journal of Medicinal Chemistry, 2020. 201: e112450. PMID[32623208].
[PubMed]. TB_07_2020.
13. Synthesis and Antimycobacterial Activity of 2,5-Disubstituted and 1,2,5-Trisubstituted benzimidazoles. Jiménez-Juárez, R., W. Cruz-Chávez, N. de Jesús-Ramírez, G.I. Castro-Ramírez, I. Uribe-González, G. Martínez-Mejía, R. Ruiz-Nicolás, C. Aguirre-Alvarado, N.S. Castrejón-Jiménez, and B.E. García-Pérez. Frontiers in Chemistry, 2020. 8: p. 433. PMID[32656177]. PMCID[PMC7325987].
[PubMed]. TB_07_2020.
14. Synthesis, Biological Evaluation and Molecular Modelling Insights of 2-Arylquinazoline Benzamide Derivatives as Anti-tubercular Agents. Malasala, S., M.N. Ahmad, J. Gour, M. Shukla, G. Kaul, A. Akhir, S. Gatadi, Y.V. Madhavi, S. Chopra, and S. Nuri. Journal of Molecular Structure, 2020. 1218: e128493. ISI[000541166600013].
[WOS]. TB_07_2020.
15. Regio- and Diastereoselective Synthesis of Spiropyrroloquinoxaline Grafted Indole Heterocyclic Hybrids and Evaluation of Their anti-Mycobacterium Tuberculosis activity. Natarajan, A., A.I. Almansour, R.S. Kumar, A. Al-Aizari, S.I. Alaqeel, S. Kansiz, V.S. Krishna, D. Sriram, and N. Dege. RSC Advances, 2020. 10(40): p. 23522-23531. ISI[000544674800002].
[WOS]. TB_07_2020.
16. Pyridine and Nitro-phenyl Linked 1,3,4-Thiadiazoles as MDR-TB Inhibitors. Patel, H., H. Jadhav, I. Ansari, R. Pawara, and S. Surana. European Journal of Medicinal Chemistry, 2019. 167: p. 1-9. PMID[30743094].
[PubMed]. TB_07_2020.
17. Synthesis and Antimycobacterial Evaluation of Pyridinyl- and Pyrazinylhydrazone Derivatives. Pinheiro, A.C., T.C.M. Nogueira, G.E. Pereira, C. Lourenco, and M.V.N. de Souza. Medicinal Chemistry Research: p. 1-7. ISI[000544549100001].
[WOS]. TB_07_2020.
18. Synthesis, Characterization, in Silico Studies and in Vitro Biological Evaluation of Isoniazid-Hydrazone Complexes. Rajan, M.P.R., R. Rathikha, R. Nithyabalaji, and R. Sribalan. Journal of Molecular Structure, 2020. 1216: e128297. ISI[000545897700004].
[WOS]. TB_07_2020.
19. Structure-Activity Relationship Analyses of Fusidic acid Derivatives Highlight Crucial Role of the C-21 Carboxylic Acid Moiety to Its Anti-mycobacterial Activity. Singh, K., G. Kaur, P.S. Shanika, G.A. Dziwornu, J. Okombo, and K. Chibale. Bioorganic and Medicinal Chemistry, 2020. 28(13): e115530. PMID[32362386].
[PubMed]. TB_07_2020.
20. Cytotoxicity and Antimycobacterial Properties of Pyrrolo[1,2-a]quinoline Derivatives: Molecular Target Identification and Molecular Docking Studies. Venugopala, K.N., V. Uppar, S. Chandrashekharappa, H.H. Abdallah, M. Pillay, P.K. Deb, M.A. Morsy, B.E. Aldhubiab, M. Attimarad, A.B. Nair, N. Sreeharsha, C. Tratrat, A. Yousef Jaber, R. Venugopala, R.P. Mailavaram, B.A. Al-Jaidi, M. Kandeel, M. Haroun, and B. Padmashali. Antibiotics, 2020. 9(5). PMID[32392709]. PMCID[PMC7277568].
[PubMed]. TB_07_2020.
21. Chemical Reactivity and Bioactivity Properties of Pyrazinamide Analogs of Acetylsalicylic acid and Salicylic Acid Using Conceptual Density Functional Theory. Villagracia, A.R., H.L. Ong, F.M. Lagua, and G. Alea. Heliyon, 2020. 6(6): e04239. PMID[32613118]. PMCID[PMC7322055].
[PubMed]. TB_07_2020.
22. Identification of Benzothiazinones Containing 2-Benzyl-2,7-diazaspiro[3.5]nonane Moieties as New Antitubercular Agents. Wang, A., C. Ma, Y. Chai, X. Liu, K. Lv, L. Fu, B. Wang, X. Jia, M. Liu, and Y. Lu. European Journal of Medicinal Chemistry, 2020. 200: e112409. PMID[32460114].
[PubMed]. TB_07_2020.
Patent Citations
23. Preparation of Oxazolidinone Compounds and Methods of Use Thereof as Antibacterial Agents. Miller, R.R., J.A. Kozlowski, P. Nantermet, D.B. Olsen, J. Su, L. Yang, T. Suzuki, B.M. Crowley, N. Wang, and L. You. Patent. 2020. 2019-CN126641 2020147504: 82pp.
[Patent]. TB_07_2020.